Michael F. Burgess Spring Works Therapeutics, Inc. (SWTX) insider trading activity
Michael F. Burgess is Head of Research & Development of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 49,584 shares of SWTX, which is worth approximately $1.92 Million. The most recent transaction as insider was on Jul 18, 2022, when has been sold 3,103 shares (Common Stock) at a price of $28.47 per share, resulting in proceeds of $88,342. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
49.6K
0%
3M change
0%
12M change
Total Value Held
$1.92 Million
Michael F. Burgess Transaction History
Also insider at
MFB
Michael F. Burgess
Head of Research & Development
Stamford, CT